ACH

Healthcare

Accendra Health, Inc. · Medical - Distribution · $250M

UQS Score — Balanced Preset
36.5
Below Average

Accendra Health, Inc. scores 36.5/100 using the Balanced preset.

UQS vs Healthcare Sector
ACH
36.5
Sector avg
32.4
Quality
Neutral
Moat
Weak
Growth
Weak
Risk
Weak
Valuation
Attractive

Unlock Full ACH Analysis

Sign in to unlock the detailed analysis behind the UQS Score.

  • Detailed 6-pillar UQS breakdown with exact scores
  • All 29 metrics with sector-calibrated comparisons
  • 6 investor presets (Buffett, Munger, Lynch, Wood, Graham, Balanced)
  • Watchlist tracking with score alerts
  • AI-generated investment perspectives across 6 preset views
  • Score history chart with change notifications
Analyze ACH in Detail →

Pro Analysis

ACH — Score History

2530354045Apr 10Apr 28May 16Jun 3Jun 21Jul 8v5
Score changes· 30/46 most recent
DateUQSQualityMoatGrowthRiskValueChange
Jul 8, 202636.643.712.024.024.394.8+0.1
Jul 3, 202636.543.712.024.024.394.50.0
Jun 30, 202636.543.712.024.024.394.30.0
Jun 27, 202636.543.712.024.024.394.5-0.1
Jun 26, 202636.643.712.024.024.394.6+0.1
Jun 25, 202636.543.712.024.024.394.5+0.7
Jun 23, 202635.838.512.024.023.598.9-0.1
Jun 19, 202635.938.512.024.023.599.2+0.1
Jun 16, 202635.838.512.024.023.599.1+0.1
Jun 15, 202635.738.512.024.023.598.10.0

ACH — Pillar Breakdown

Quality

43.7/100 (25%)

Accendra Health, Inc. has average quality metrics, with room for improvement in margins or capital efficiency.

Capital Efficiency (ROIC)Weak

How effectively capital is deployed to generate returns.

Return on EquityStrong

Profitability relative to shareholders' equity.

Operating ProfitabilityWeak

Ability to convert revenue into operating profit.

Net ProfitabilityWeak

Bottom-line profit as a share of revenue.

Gross Profit / AssetsStrong

Asset productivity — how much gross profit each dollar of assets generates.

Cash GenerationWeak

Free cash flow relative to market value.

Growth

24.0/100 (20%)

Accendra Health, Inc. faces growth headwinds with declining or stagnant revenue trends.

Recent Revenue TrendWeak

Revenue trajectory over the last twelve months.

3Y Revenue CAGRWeak

Compound annual revenue growth rate over 3 years.

EPS GrowthWeak

Year-over-year earnings per share growth.

Forward Revenue OutlookWeak

Analyst consensus for future revenue growth.

Forward EPS GrowthStrong

Analyst consensus for future earnings growth.

Risk

24.3/100 (15%)

Accendra Health, Inc. presents elevated risk with concerns around leverage or financial stability.

Financial LeverageWeak

Debt levels relative to earnings capacity.

Debt/EquityStrong

Total debt relative to shareholder equity.

Current RatioWeak

Short-term liquidity — ability to pay near-term obligations.

Interest CoverageWeak

Earnings capacity relative to interest payments.

Valuation

94.3/100 (15%)

Accendra Health, Inc. appears attractively valued relative to its earnings, cash flows, and sector peers.

Earnings YieldStrong

Inverse of forward P/E — higher yield means cheaper stock.

PEG RatioStrong

P/E relative to earnings growth — lower is more attractive.

EV/EBITDA vs SectorStrong

Enterprise value multiple relative to sector median.

Moat

12/100 (25%)

Accendra Health, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for ACH.

Score Composition

Quality
43.7×25%10.9
Growth
24.0×20%4.8
Risk
24.3×15%3.6
Valuation
94.3×15%14.1
Moat
12.0×25%3.0
Total
36.5Below Average

Financial Data

More Stock Analysis

How is the ACH UQS Score Calculated?

The UQS (Unified Quality Score) for Accendra Health, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.

Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.

Moat (25%) assesses Accendra Health, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.

Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.

Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.

Valuation (15%) measures whether Accendra Health, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.

Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.